Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Abbott Laboratories    ABT   US0028241000

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Abbott Laboratories : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Sales38 85139 87421 84822 41423 63124 935
Operating income (EBITDA)11 21612 6164 9745 4285 8636 385
Operating profit (EBIT)9 0109 8334 0464 1434 5794 766
Pre-Tax Profit (EBT)5 1996 2632 521---
Net income4 7295 9632 5762 0243 0273 619
EPS ( $)3,013,721,621,392,032,32
Dividend per Share ( $)1,881,670,640,881,061,21
Yield4,31%3,83%1,47%2,02%2,42%2,77%
Announcement Date01/25/2012
12:46pm
01/23/2013
12:47pm
01/22/2014
12:44pm
---
Finances - Leverage
Abbott Laboratories : Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Debt8 6029 6743 0862 5102 3211 514
Finance------
Operating income (EBITDA)11 21612 6164 9745 4285 8636 385
Leverage
(Debt/EBITDA)
0,77x0,77x0,62x0,46x0,40x0,24x
Capital Expenditure1 4921 7951 1451 0981 0831 275
Book Value Per Share (BVPS)15,6 $17,0 $16,3 $16,6 $18,0 $19,6 $
Cash Flow per Share5,72 $5,85 $2,11 $2,95 $2,98 $3,50 $
Announcement Date01/25/2012
12:46pm
01/23/2013
12:47pm
01/22/2014
12:44pm
---
Balance Sheet Analysis
Abbott Laboratories : Balance Sheet Analysis
Assessed data source :
© 2014 Thomson Reuters
Advertisement
Financial Ratios

Size 2014e 2015e
Capitalization 65 546 M$ -
Entreprise Value (EV) 68 056 M$ 67 867 M$
Valuation 2014e 2015e
PER (Price / EPS) 31,3x 21,5x
Capitalization / Revenue 2,92x 2,77x
EV / Revenue 3,04x 2,87x
EV / EBITDA 12,5x 11,6x
Yield (DPS / Price) 2,02% 2,42%
Profitability 2014e 2015e
Operating Margin (EBIT / Sales) 18,5% 19,4%
operating Leverage (Delta EBIT / Delta Sales) 0,93x 1,94x
Net Margin (Net Profit / Revenue) 9,03% 12,8%
ROA (Net Profit / Asset) 7,75% 7,35%
ROE (Net Profit / Equities) 13,8% 13,5%
Rate of Dividend 63,1% 52,1%
Balance Sheet Analysis 2014e 2015e
CAPEX / Sales   4,90% 4,58%
Cash Flow / Sales (Taux d'autofinancement) 19,8% 18,9%
Capital Intensity (Assets / Sales) 1,17x 1,74x
Financial Leverage (Net Debt / EBITDA) 0,46x 0,40x
Price Earning Ratio
Abbott Laboratories : Price Earning Ratio
EPS & Dividend
Abbott Laboratories : EPS Dividend
Dynamic quotes  
ON
| OFF